Dr. Kung is presently an Associate Professor in the Department of Immunology at the University of Manitoba.  At University of Manitoba, Dr. Kung established a CFI-funded laboratory that currently studies natural killer (NK)-cell migrations, NK-dendritic cell crosstalk and NK-based immunotherapy in Head and Neck, and breast cancer models.  He is currently the Director of two core platforms that, respectively, housed 4 collections of lentiviral-based shRNA libraires (mouse and human GIPZ or LKO shRNA clones) and provided lentiviral vector production services at U Manitoba.  In collaboration with Dr. Francis Lin in the Department of Physics and Astronomy at U Manitoba, Dr. Kung has been actively creating a microfluidic platform to study NK-cell migratory properties in vitro.